well lets see.....lewis said on the conference call that the market likes that they offered up millions of shares to raise $25 million in the $4 range - I believe they took a combined total of $20 million in loans - have $45 million in cash - lewis has bought shares well above our current share price. One would think the company would some how defend themselves by proving to shareholders all of these insider buys, loans, and selling additional shares by increasing the share price. and btw....over a year ago they said they knew what they were going to do with iplex - which to me means more then licensing it to premacure and pcut
Management has also re-done the company website which summarizes the company as 100% Arikace. Many of us long-time holders don't believe Insmed is a one trick pony but by completely disregarding our company and IP before Arikace, Management is also subjecting us to days like yesterday, when the market (over?) reacts.